Valeant Pharmaceuticals International VP of Engineering Salaries in Lansing, MI
The average Valeant Pharmaceuticals International VP of Engineering in Lansing, MI earns an estimated $227,686 annually, which includes an estimated base salary of $184,965 with a $42,721 bonus. Valeant Pharmaceuticals International's VP of Engineering compensation is $23,544 less than the US average for a VP of Engineering. VP of Engineering salaries at Valeant Pharmaceuticals International in Lansing, MI can range from $95,000 - $550,000.
In Lansing, MI, The Engineering Department at Valeant Pharmaceuticals International earns $12,034 more on average than the Design Department.
Last updated 2 years ago.
- $184,965
- avg. base
- $42,721
- avg. bonus
VP of Engineering Salaries at Valeant Pharmaceuticals International
In Lansing, MI, VPs of Engineering earn $15,469 more than Directors of Engineering.
Compensation at Valeant Pharmaceuticals International by Department
In Lansing, MI, The Engineering Department averages $12,034 more than the Design Department, and $1,202 less than the Business Development Department
VP of Engineering Compensation by Gender (All Companies)
The average female VP of Engineering at companies similar size to Valeant Pharmaceuticals International reported making $281,893, while the average male VP of Engineering at similar sized companies reported making $263,157.
VP of Engineering Compensation by Ethnicity (All Companies)
The average Caucasian VP of Engineering at companies similar size to Valeant Pharmaceuticals International reported making $286,544, while the average African American/Black VP of Engineering at similar sized companies reported making $187,625.
How VPs of Engineering at Valeant Pharmaceuticals International Rate Their Compensation
The majority of VPs of Engineering at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of VPs of Engineering at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
